Clinical Trial Update: Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and tolerability of tacrolimus extended-release (Astagraf XL) in HLA-sensitized kidney transplant recipients has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Recipient Conditions May Be Implied

Drugs mentioned

• Astagraf XL (Tacrolimus)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: End Stage Renal Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-12-30